Learn More
Medchemexpress LLC Vapreotide acetate | 849479-74-9 | >98.16% | 1191.42 | 25 MG

Supplier: Medchemexpress LLC 25MGHYP0061A
Vapreotide acetate is a neurokinin-1 (NK1) receptor antagonist, characterized by an IC50 of 330 nM. It attenuates Substance P (SP)-triggered intracellular calcium increases and NF-κB activation, while inhibiting SP-induced IL-8 and MCP-1 production. It also inhibits HIV-1 infection and significantly reduces GH-, PRL, and/or alpha-subunit release from pituitary adenoma cells. The compound exhibits moderate-to-high affinities for SSTR2, -3, and -5.
- Neurokinin-1 (NK1) receptor antagonist.
- Attenuates SP-triggered calcium increases, NF-κB activation.
- Inhibits SP-induced IL-8 and MCP-1 production.
- Inhibits HIV-1 infection; reduces GH, PRL, and alpha-subunit release.
- Moderate-to-high affinities for SSTR2, -3, and -5.
- Can inhibit androgen-independent prostate cancer growth and decrease collateral circulation in cirrhotic rats.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.